Dr. Amory’s principal area of research is in male reproductive health, specifically focused on the areas of male contraception, male infertility and the treatment of hypogonadism. He was elected to membership in the American Society of Clinical Investigation in 2013. Currently, he serves as the Associate Editor of Andrology and as a member of the NIH’s study section on cellular and molecular reproduction.
ALDH1a2 inhibitors for male contraception
The goal of this project is to develop safe, effective contraceptive for men based on the development of inhibitors of ALDH1a2.
Prostate and Cardiovascular Effects of Male Hormonal Contraceptive Regimens
The goal of this project is to understand the extra-gonadal effects of male hormonal contraception, with particular focus on the molecular and tissue effects of male hormonal contraception on the prostate and cardiovascular system in normal young men.
Men's Reproductive Health Research at the University of Washington
The major goal of this program is to support the early careers of junior clinical investigators in male reproductive health.
Retinoic Acid in Male Infertility
The major goal of this grant is to determine the impact of treating men with infertility with 13-cis-retinoic acid.